pazufloxacin has been researched along with E coli Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arakawa, Y; Kato, H; Kimura, K; Konda, T; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K | 1 |
| Akasaka, S; Matsumoto, T; Muratani, T; Takahashi, K; Yamada, Y | 1 |
| Ajisawa, A; Bamba, T; Fukuda, H; Hosoda, S; Imai, T; Irimajiri, S; Katoh, K; Masuda, G; Matsumoto, F; Mizuno, Y; Mori, M; Murata, M; Negishi, M; Nitta, Y; Obana, M; Ohnishi, K; Sagara, H; Saito, M; Sakurai, I; Takahashi, T; Takizawa, Y; Tomizawa, I; Tsunoda, T; Yamaguchi, T; Yoshikawa, K | 1 |
1 trial(s) available for pazufloxacin and E coli Infections
| Article | Year |
|---|---|
The efficacy of sequential therapy using pazufloxacin followed by oral fluoroquinolones for treatment of pyelonephritis.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Administration Schedule; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Oxazines; Pyelonephritis; Treatment Outcome; Virulence Factors | 2013 |
2 other study(ies) available for pazufloxacin and E coli Infections
| Article | Year |
|---|---|
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chitosan; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Malates; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial; Uncoupling Agents | 2007 |
[Basic and clinical studies of pazufloxacin on infectious enteritis research group of T-3761 on infectious enteritis].
Topics: 4-Quinolones; Anti-Infective Agents; Bacterial Infections; Carrier State; Cholera; Drug Resistance, Microbial; Dysentery, Bacillary; Enteritis; Escherichia coli Infections; Fluoroquinolones; Humans; Oxazines; Salmonella Infections | 1996 |